FDA Nods to Novartis' Kesimpta for Relapsing Forms of MS
Zacks via Yahoo Finance· 6 months agoNovartis AG NVS announced that the FDA has approved the supplemental biologics license application...
Novartis wins FDA approval to repurpose leukaemia drug against multiple sclerosis
Reuters via Yahoo News· 6 months agoNovartis on Thursday won U.S. Food and Drug Administration (FDA) approval to repurpose an...
Genmab A/S (GMAB) Q4 2020 Earnings Call Transcript
Motley Fool· 1 week agoGenmab is not under an obligation to update statements regarding the future, nor to confirm such statements in relation to actual results unless this is...
Edited Transcript of GMAB.CO earnings conference call or presentation 4-Nov-20 5:00pm GMT
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoWe have seen significant advances in our and our partners' pipelines throughout 2020, and the third quarter was no exception. On a single day in August, the U.S. FDA granted approvals to Novartis ...
Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates
Zacks via Yahoo Finance· 4 weeks agoThis week several large drugmakers, Pfizer PFE, Merck, MRK, AbbVie ABBV Lilly LLY, Glaxo GSK and...
TG Therapeutics Shares Climb on Study Results
GuruFocus.com via Yahoo Finance· 2 months agoAfter a protracted wait, TG Therapeutics Inc. (NASDAQ:TGTX) shareholders finally got rewarded for their patience last month when the stock began a rapid...
Roche Expands Multiple Sclerosis Portfolio, Starts Studies
Zacks via Yahoo Finance· 6 months agoRoche Holding AG's RHHBY subsidiary, Genentech, announced that it has initiated an innovative phase...
Novartis' (NVS) Q3 Earnings Surpass Estimates, Sales Miss
Zacks via Yahoo Finance· 4 months agoThe Innovative Medicines division recorded sales of $9.8 billion, up 1% year over year. Within this...
Roche studies Ocrevus, experimental drug in bid to defend MS franchise
Reuters via Yahoo News· 6 months agoRoche is seeking to defend ground gained in treating MS since winning approval for Ocrevus three...
Pharma Stock Roundup: SNY, JNJ Acquisition Deals, FDA Approvals
Zacks via Yahoo Finance· 6 months agoRecap of the Week's Most Important Stories J&J to Buy Momenta for $6.5B: J&J has offered $6.5...
Yahoo Web Search
Trending Now
